PrimeX News

Gold (XAUUSD), Silver, Platinum Forecasts – Gold Tests Multi-Month Lows As Sell-Off Continues
Wed, 24 Jun 2026 17:08:31 GMT
S&P500 and Nasdaq Index: US Stocks Rise as Oil Falls, Micron Earnings Loom
Wed, 24 Jun 2026 17:02:27 GMT
Crude Oil Analysis: $73 Support Holds as Borrowed Supply Faces Rollover Risk
Wed, 24 Jun 2026 17:02:11 GMT
Gold Price Forecast – The Final Washout Is Now in Progress
Wed, 24 Jun 2026 13:57:28 GMT
Crude Oil Price Analysis – Crude Oil Continues to Drop
Wed, 24 Jun 2026 13:42:52 GMT
Natural Gas Price Analysis – Natural Gas Continues to Range Trade
Wed, 24 Jun 2026 13:35:54 GMT

First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

NAMS

NewAmsterdam Pharma Company N.V. Ordinary Shares

32.26

USD

+0.86

+2.75%

Jun 24, 13:59 UTC -4

Open

NAMS News & Forecasts

featured

NewAmsterdam Pharma Company N.V. (NAMS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

featured

NewAmsterdam Pharma Company N.V. (NAMS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

featured

NewAmsterdam Pharma Company N.V. (NAMS) Discusses Clinical Development Update and Interim Analysis Plans for PREVAIL Trial Transcript

featured

NewAmsterdam Pharma Sets PREVAIL Interim Analysis for Q4 2026 on Encouraging Blinded Trends

featured

Zacks Investment Research

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates

featured

NewAmsterdam Pharma: Cholesterol-Lowering Player Is A Risk-On Buy Today

Advertisement

Advertisement

Advertisement